click below
click below
Normal Size Small Size show me how
NMB Pharm
Y2- NMB Unit Pharm MOA
| Question | Answer |
|---|---|
| Phenytoin (Dilantin) | Selectively binds to inactivate Na+ channels and decrease Glutamate release from excitatory presynaptic neurons. |
| Carbamazapine | Stabilizes the inactivated state of Na+ channels. Potentiate GABA receptors. |
| Lamotrigine | Blocks voltage gated Na+ channels. Decrease release of Glutamate from excitatory NTs |
| Valproic acid | Increase Na+ channel inactivation. Inhibits GABA transaminase |
| Gabapentin | Binds to presynaptic N-type Ca++ channels. Decrease NT Release |
| Topiramate | Block voltage gated Na+ channels. Antagonize AMPA/kainate glutamate receptors. |
| Phenobarbital | Bind GABAa receptor and prolong duration of CL- channel opening |
| Ethosuximide | Blocks thalamic T-type Ca++ channels. |
| Lorazepam (Benzo) Diazepam | bind GABAa receptor at interface of alpha and gamma subunits. Increase frequency of of GABA binding and increased frequency of chloride channel opening. |
| Short Acting (highest addiction potential) triazolam, oxazepam, alprazolam, midazolam | bind GABAa receptor at interface of alpha and gamma subunits. Increase frequency of of GABA binding and increased frequency of chloride channel opening. Fix OD with Flumenazil |
| Medium Acting estazolam, lorazepam, temazepam | bind GABAa receptor at interface of alpha and gamma subunits. Increase frequency of of GABA binding and increased frequency of chloride channel opening. Fix OD with Flumenazil |
| Long Acting (greatest fall risk) chlordiazepoxide, diazepam, flurazepam, clonazepam, clorazepate | bind GABAa receptor at interface of alpha and gamma subunits. Increase frequency of of GABA binding and increased frequency of chloride channel opening. Fix OD with Flumenazil |
| Tigabine | Selective GABA reuptake inhibitor |
| Vigabatrin | Irreversibly inhibit GABA transaminase |
| Levetiracetam | Inhibit voltage dependent N=type Ca++ channels. Bind to synaptic proteins that modulate neurotransmitter release. |
| Oxycarbazepine | Na+ channel blocker |
| Felbamate | Has an effect on GABA receptor binding sites |
| Lacosamide | Enhance slow activation of Na+ channels and interacts with CRMP-2 |
| Rufinamide | Prolongs the inactivation state of the Na+ channel |
| Sulthiame | Carbonic anhydrase inhibitor |
| Zonisamide | Binds Na+ channels, Voltage sensitive Ca++ channels, partial CAI |